The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht.

Slides:



Advertisements
Similar presentations
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Advertisements

Briefing on MHRA routine inspection of non-commercial clinical trials
Medicines and Healthcare products Regulatory Agency (MHRA) Statutory Good Clinical Practice (GCP) Inspection of Cardiff University.
Tips to a Successful Monitoring Visit
Working together for better Research - Collaborative research with BCUHB Dr Nefyn Williams & Dr Richard Tranter, NWORTH Associate Clinical Directors &
ISO in Histopathology Louise O’Callaghan MSc FAMLS
Kenya AIDS Vaccine Initiative
Laboratory Accreditation – An Assessors Perspective Dr Jonathan berg City Hospital, Birmingham.
© Clinical Research Practice Clinical Research Organization and Management 1.
Good Clinical Practices Regulatory Guidelines for the Conduct of Clinical research Introduction to Research Pharmacy Services Javier Palacios, R.Ph. Sponsored.
Monitoring and Auditing
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
1 Investigator-Initiated Clinical Research Planning, Developing, Conducting, Managing, and Succeeding Wm. Hirschhorn, M.S. Director, OCT & RQI and Adj.
Contact: For education: Kornelia Hathaway, Education & Training Manager, For.
ABS Health, LLC 12466, E Washington Blvd, Whittier, CA – Phone
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
Good Clinical Practice GCP
Healing Hands Clinical Research Services is a clinical Research Service Provider which has broad spectrum of.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Federal Institute for Drugs and Medical Devices The BfArM is a Federal Institute within the portfolio of the Federal Ministry of Health 1 Quality of Bioequivalence.
Monitoring and Special Considerations for Multi-Center Trials
Regulatory Overview.
Quality Assurance in Bio-availability / Bio-equivalence studies. DR
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
05/09/2015www.ecrin.org1 European Clinical Research Infrastructures Network
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Enriching Drug Development through Insightful Trial Design
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Investigating recent developments in clinical trials in Belgium: analysis of the data available at the Federal Agency for Medicines and Health Products.
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
Bundesinstitut für Arzneimittel und Medizinprodukte Pt WHO-consultant 1 WHO Training Workshop on Pharmaceutical Quality, Good Manufacturing Practice &
How to Start An Industry Sponsored Clinical Trial
Office of Human Research Protection Georgia Health Sciences University.
RIHES JJ: Required Training Version 7.0 Effective Date 27 JAN 2011 Boonlure Pruenglampoo 15 Jan 2014 วันพุธที่ 15 มกราคม พ. ศ 2557 RIHES-JJ Version 7.0.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Using Australian Clinical Sites – Challenges for International Sponsors Prof A J (Tony) Webber Clinical Network Services Pty Ltd Brisbane, Australia.
Content 1.About us 2.Mission & Vision 3.Values 4.Facility 5.Quality Management System 6.Services 7.Why PCS.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
September 18, 2009 Prepared for DIA GCP QA SIAC teleconference 1 GCP QA for Russia and the Ukraine.
Briefing on MHRA routine inspection of non-commercial clinical trials
Remote Site Initiation Visits
Consultancy expertise for ISO design and implementation
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
Recent Evolution of New Drug Review and Approval System in Korea
Responsibilities of Sponsor, Investigator and Monitor
The Essentia Institute of Rural Health (EIRH) is
נמטוציטים משושנת ים Eli. S Lec. No.2.
Ensuring Successful Technology Transfer for Clinical Manufacture
Regulation EU 536/2014 on clinical trials
LNH Pharma A Trusted Partner.
Dr Charlotte Lemech Medical Director, Scientia Clinical Research
Good Clinical Practice
The WHO Prequalification of Medicines Programme Capacity building agenda Dr Milan Smid.
Dr Samvel Azatyan Technical Officer Regulatory Support
Building a caring correctional system that truly belongs to all
Building a caring correctional system that truly belongs to all
Building a caring correctional system that truly belongs to all
Presentation transcript:

The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht

Mission Statement To contribute to the development of new drugs by conducting early phase clinical trials (phase 0-I-II) in compliance with (inter)national legislation and quality standards

essential part in chain of drug development preclinical → early phase → phase 3&4 by filling the gap in the drug research chain facilitates translational research Position in MUMC-holding/valorisation chain

Close collaboration with Drug Research Unit Ghent (DRUG): 1 CEO for 2 units ↑ possibilities of conducting larger trials or trials with difficult recruitment DRUM can take advantage of the elaborated quality management system and training at DRUG Joint PR for internal and external sponsors Cross-fertilisation of know-how/methods … Strategic alliance

sponsors Pharmaceutical industry (+ nutriceuticals) Non for profit organisations MUMC Other University departments

What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

Quality quality control – first party (internal) audits scheduled on main procedures ad hoc for (near) errors –training in SOP (all SOP’s revised within 2 yrs) –close feedback on the spot / approval system quality assurance – 1 GCP-ICH third party audit/yr –ISO 9001:2008 → 1 ISO audit/yr (within 1 year?)

What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

Large expertise takes advantage of experts in 2 knowledge centers: MUMC - U(Z)Gent → many therapeutic areas → high tec investigations experience in early phase clinical drug research –principal investigator: 24 years –investigator: 4 years

What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

Timelines (cfr DRUG) EC: Ethics Committee Number of working days Median 2005 Median 2006 Median 2007 Median 2008 Median 2009 From submission EC to final answer EC 14, From submission EC to first dosing From last monitoring visit to release of study data to monitor 13331

What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

High flexibility Dose adjustments Pharmacy with GMPz Pharmacell bv with full GMP Additional safety measures Puts pressure on working hours/social environment of staff, particularly in the early years

What can DRUM offer the MUMC Service center for early phase drug investigations Take advantage of knowledge center (experts in MUMC) Facilitates education (training) in Medicine/ Health Sciences/clinical pharmacologist

staff Principal investigator - investigator - quality coordinator - managing coordinator - clinical research coordinator - trial nurse - office manager investigator/principal investigator experienced in early phase studies All are well-trained training at DRUG Highly motivated Bank personnel: trial nurses / co-investigators

facilities 16 beds for clinical research and overnight stay 2 sample handling laboratories (temperature controlled) 1 drug storage room (temperature controlled / alarm) 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm) 2 refrigerators (temperature controlled / alarm) offices, archive, meeting room, reception, kitchen, storage room

facilities 16 beds for clinical research and overnight stay 2 sample handling laboratories (temperature controlled) 1 drug storage room (temperature controlled / alarm) 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm) 2 refrigerators (temperature controlled / alarm) offices, archive, meeting room, reception, kitchen, storage room

facilities 16 beds for clinical research and overnight stay 2 sample handling laboratories (temperature controlled) 1 drug storage room (temperature controlled / alarm) 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm) 2 refrigerators (temperature controlled / alarm) offices, archive, meeting room, reception, kitchen, storage room

Ready to start!

Summary Centre of Excellence (qualified staff / approval / external audits / ISO 9001:2008) short timelines, high flexibility takes advantage of university knowledge centre

YES, we can!